Skip to main content
CAMBRIDGE NUTRITIONAL SCIENCES PLC logo

CAMBRIDGE NUTRITIONAL SCIENCES PLC — Investor Relations & Filings

Ticker · CNSL ISIN · GB00B1VCP282 LEI · 2138007U9P4BTZTYIR92 IL Manufacturing
Open in API
Filings indexed 532 across all filing types
Latest filing 2025-04-08 Regulatory Filings
Country GB United Kingdom
Listing IL CNSL

About CAMBRIDGE NUTRITIONAL SCIENCES PLC

https://www.cnsplc.com/

Cambridge Nutritional Sciences PLC is a medical diagnostics company that develops, manufactures, and distributes products focused on promoting a personalised approach to health. The company specialises in a range of tests associated with food sensitivity and gut health. Utilising advanced diagnostic technology, its products are designed for use by healthcare professionals and their patients to identify potential food reactions and guide lifestyle and dietary changes. The company's goal is to enable individuals to improve their long-term health and wellbeing by understanding how their diet may be contributing to various health issues.

Recent filings

Filing Released Lang Actions
Grant of Options
Regulatory Filings Classification · 1% confidence The document is an RNS announcement from Cambridge Nutritional Sciences PLC regarding the 'Grant of Options' to its Chief Executive Officer, James Cooper. It includes the mandatory 'Notification and public disclosure of transactions by persons discharging managerial responsibilities' (PDMR) table. While this involves a director, it is specifically a grant of options rather than a market trade (dealing) by the director. Under the provided definitions, this fits the 'Director's Dealing' (DIRS) category as it reports personal share-related transactions/grants involving company executives.
2025-04-08 English
Appointment of Chief Executive Officer
Board/Management Information Classification · 1% confidence The document is an official announcement from Cambridge Nutritional Sciences plc regarding the appointment of a new permanent Chief Executive Officer (James Cooper). This falls directly under the category of changes in senior management.
2025-04-01 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by Cambridge Nutritional Sciences PLC. It details a change in share ownership by Spreadex LTD, crossing a specific threshold. This is a standard regulatory disclosure for major shareholding notifications, which corresponds to the MRQ filing category.
2025-03-21 English
Omega Diagnostics Summons Update
Legal Proceedings Report Classification · 1% confidence The document is identified by the header 'RNS Number' and contains standard boilerplate language referencing RNS, the news service of the London Stock Exchange, and the Financial Conduct Authority (FCA). The content itself is a brief update regarding a legal summons ('Omega Diagnostics Summons Update') and a guilty plea entered in court. This type of short, material, non-periodic announcement that is distributed via the official regulatory news service (RNS) fits best under the general 'Regulatory Filings' category, as it is not a specific financial report (like 10-K, IR, ER) or a specific corporate action announcement (like DIV, CAP, DIRS). Given the source and nature, RNS is the most appropriate classification.
2025-03-19 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled as 'TR-1: Standard form for notification of major holdings' and contains details about an 'acquisition or disposal of financial instruments' by a shareholder ('Cantor Fitzgerald Europe'), crossing a voting rights threshold (from 5.207400% to 6.100400%). This type of filing, which reports changes in significant share ownership, directly corresponds to the Major Shareholding Notification category. The presence of 'RNS Number' and the closing statement referencing the London Stock Exchange confirms it is a regulatory disclosure, but the specific content points to MRQ rather than the general RNS fallback.
2025-03-18 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is clearly identified by the 'RNS Number' header and explicitly mentions 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details a transaction involving the purchase of shares by a Director/PDMR (Carolyn Rand, Non-Executive Chair). This type of insider transaction reporting falls directly under the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific content dictates the DIRS classification over the general RNS fallback.
2025-02-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.